ANDE Stock Analysis: The Andersons | NASDAQ

Food Distribution | NASDAQ, USA | Market Cap: 2.301m USD | 12M Return: 54% | US0341641035 | Charts, Fundamentals & Technical Analysis

Grains, Fertilizers, Ethanol, Biofuels
Total Rating 65
Safety 79
Buy Signal -0.13
Food Distribution
Industry Rotation: +2.9
Market Cap: 2.30B
Avg Turnover: 22.4M
Risk 3d forecast
Volatility38.8%
VaR 5th Pctl6.44%
VaR vs Median0.80%
Reward TTM
Sharpe Ratio1.29
Rel. Str. IBD55.4
Rel. Str. Peer Group55.4
Character TTM
Beta0.466
Beta Downside0.722
Hurst Exponent0.472
Drawdowns 3y
Max DD46.94%
CAGR/Max DD0.21
CAGR/Mean DD0.58
EPS (Earnings per Share) EPS (Earnings per Share) of ANDE over the last years for every Quarter: "2021-09": 0.15, "2021-12": 1.14, "2022-03": 0.18, "2022-06": 2.39, "2022-09": 0.5, "2022-12": 0.98, "2023-03": 0.2, "2023-06": 1.52, "2023-09": 0.13, "2023-12": 1.59, "2024-03": 0.16, "2024-06": 1.15, "2024-09": 0.8, "2024-12": 1.36, "2025-03": 0.12, "2025-06": 0.24, "2025-09": 0.84, "2025-12": 2.04, "2026-03": 1.12, "2026-06": 2.15,
EPS CAGR: 11.96%
EPS Trend: 42.6%
Last SUE: 2.62
Qual. Beats: 4
Revenue Revenue of ANDE over the last years for every Quarter: 2021-09: 2998.824, 2021-12: 3782.702, 2022-03: 3977.954, 2022-06: 4450.617, 2022-09: 4219.325, 2022-12: 4677.488, 2023-03: 3881.238, 2023-06: 4020.183, 2023-09: 3635.691, 2023-12: 3213, 2024-03: 2718.217, 2024-06: 2795.205, 2024-09: 2620.988, 2024-12: 3123.138, 2025-03: 2659.098, 2025-06: 3135.869, 2025-09: 2677.712, 2025-12: 2536.249, 2026-03: 2627.266, 2026-06: 3097.66,
Rev. CAGR: -11.50%
Rev. Trend: -84.5%
Last SUE: -0.44
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -3.6% 5
Feb +4.7% 49
Mar -0.4% 5
Apr -0.8% 8
May -6.9% 34
Jun +2.7% 5
Jul +1.7% 28
Aug +0.1% 5
Sep -1.7% 18
Oct +5.2% 15
Nov +0.9% 13
Dec +2.4% 14

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ANDE The Andersons

The Andersons, Inc. (ANDE) is a U.S.-based agriculture and renewable fuels company operating in the United States, Canada, Mexico, and other international markets through two main business segments. The Agribusiness segment handles the merchandising of grain commodities such as corn, wheat, and soybeans, along with the manufacture, distribution, and retail of agricultural plant nutrients and fertilizers. This segment also provides logistics services for physical commodities, including whole grains, feed ingredients, and fuel products. The Renewables segment is involved in the production, purchase, sale, merchandising, and trading of ethanol and its co-products, as well as the trading of other biofuels and renewable feedstocks. Founded in 1947 and headquartered in Maumee, Ohio, The Andersons has been publicly traded since its 1996 IPO on NASDAQ and is classified as a mid-cap stock within the consumer staples sector.

The company operates as a food distributor under the GICS classification, reflecting its central role in moving agricultural products through the supply chain. Its ethanol production ties directly to U.S. renewable fuel programs that require blending biofuels like ethanol into gasoline, providing a structural source of demand. As a commodity merchandiser, The Andersons earns margins from the trading and physical handling of grains and biofuel feedstocks, while its logistics operations generate service-based revenue tied to the storage, transportation, and handling of agricultural goods.

Headlines to Watch Out For
  • Ethanol margins narrow as corn prices rise sharply
  • Grain merchandising revenue tracks US harvest yield
  • Fertilizer and plant nutrient sales hinge on spring planting
Piotroski VR-10 (Strict) 4.5
Net Income: 177.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.86 > 1.0
NWC/Revenue: 6.42% < 20% (prev 9.49%; Δ -3.06% < -1%)
CFO/TA 0.09 > 3% & CFO 321.9m > Net Income 177.3m
Net Debt (905.8m) to EBITDA (375.5m): 2.41 < 3
Current Ratio: 1.51 > 1.5 & < 3
Outstanding Shares: last quarter (34.3m) vs 12m ago 0.33% < -2%
Gross Margin: 7.87% > 18% (prev 6.30%; Δ 1.57% > 0.5%)
Asset Turnover: 316.1% > 50% (prev 334.8%; Δ -18.69% > 0%)
Interest Coverage Ratio: 3.56 > 6 (EBIT TTM 206.8m / Interest Expense TTM 58.1m)
Altman Z'' 3.43
A: 0.20 (Total Current Assets 2.08b - Total Current Liabilities 1.38b) / Total Assets 3.47b
B: 0.32 (Retained Earnings 1.11b / Total Assets 3.47b)
C: 0.06 (EBIT TTM 206.8m / Avg Total Assets 3.46b)
D: 0.62 (Book Value of Equity 1.32b / Total Liabilities 2.12b)
Altman-Z'' = 3.43 = A
Beneish M -3.20
DSRI: 1.02 (Receivables 755.2m/783.9m, Revenue 10.9b/11.5b)
GMI: 0.80 (GM 6.30% / 7.87%)
AQI: 1.06 (AQ_t 0.12 / AQ_t-1 0.11)
SGI: 0.95 (Revenue 10.9b / 11.5b)
TATA: -0.04 (NI 177.3m - CFO 321.9m) / TA 3.47b)
Beneish M = -3.20 (Cap -4..+1) = AA
What is the price of ANDE shares?

As of October 12, 2026, the stock is trading at USD 63.89 with a total of 291,766 shares traded. Over the past week, the price has changed by -5.66%, over one month by -9.70%, over three months by -14.31% and over the past year by +53.96%.

Current recommended Stop Loss: 61.20 (which is 4.2% or 1.3 ATR below the current price).

Is ANDE a buy, sell or hold?

The Andersons has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy ANDE.

  • StrongBuy: 3
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the ANDE price?
Analysts Target Price 88.3 38.3%
The Andersons (ANDE) - Fundamental Data Overview as of 12 October 2026
Market Cap USD = 2.30b (2.30b USD * 1.0 USD.USD)
P/E Trailing = 13.0986
P/E Forward = 20.9205
P/S = 0.2103
P/B = 1.7363
P/EG = 0.8947
Revenue TTM = 10.9b USD
EBIT TTM = 206.8m USD
EBITDA TTM = 375.5m USD
Long Term Debt = 563.5m USD (from longTermDebt, last quarter)
Short Term Debt = 337.3m USD (from shortTermDebt, last quarter)
Debt = 972.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 71.5m
Net Debt = 905.8m USD (calculated: Debt 972.3m - CCE 66.5m)
Enterprise Value = 3.21b USD (2.30b + Debt 972.3m - CCE 66.5m)
Interest Coverage Ratio = 3.56 (Ebit TTM 206.8m / Interest Expense TTM 58.1m)
EV/FCF = 56.34x (Enterprise Value 3.21b / FCF TTM 56.9m)
FCF Yield = 1.77% (FCF TTM 56.9m / Enterprise Value 3.21b)
FCF Margin = 0.52% (FCF TTM 56.9m / Revenue TTM 10.9b)
Net Margin = 1.62% (Net Income TTM 177.3m / Revenue TTM 10.9b)
Gross Margin = 7.87% ((Revenue TTM 10.9b - Cost of Revenue TTM 10.1b) / Revenue TTM)
Gross Margin QoQ = 7.22% (prev 8.96%)
Tobins Q-Ratio = 0.92 (Enterprise Value 3.21b / Total Assets 3.47b)
Interest Expense / Debt = 5.98% (Interest Expense 58.1m / Debt 972.3m)
Taxrate = 15.94% (34.2m / 214.7m)
NOPAT = 173.8m (EBIT 206.8m * (1 - 15.94%))
Current Ratio = 1.51 (Total Current Assets 2.08b / Total Current Liabilities 1.38b)
Debt / Equity = 0.74 (Debt 972.3m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 2.41 (Net Debt 905.8m / EBITDA 375.5m)
Debt / FCF = 15.91 (Net Debt 905.8m / FCF TTM 56.9m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.12% (Net Income 177.3m / Total Assets 3.47b)
RoE = 14.15% (Net Income TTM 177.3m / Total Stockholder Equity 1.25b)
RoCE = 11.38% (EBIT 206.8m / Capital Employed (Equity 1.25b + L.T.Debt 563.5m))
RoIC = 7.35% (NOPAT 173.8m / Invested Capital 2.37b)
WACC = 6.85% (E(2.30b)/V(3.27b) * Re(7.62%) + D(972.3m)/V(3.27b) * Rd(5.98%) * (1-Tc(0.16)))
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -1.80 | Cagr: -0.78%
[DCF] Terminal Value 77.97% ; FCFF base≈44.9m ; Y1≈51.4m ; Y5≈75.7m
[DCF] Fair Price = 6.88 (EV 1.14b - Net Debt 905.8m = Equity 233.6m / Shares 34.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 42.63 | EPS CAGR: 11.96% | SUE: 2.62 | # QB: 4
Revenue Correlation: -84.54 | Revenue CAGR: -11.50% | SUE: -0.44 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.07 | Chg30d=+0.00% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=6.11 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+89.2% | GrowthRev=+5.6%
EPS next Year (2027-12-31): EPS=6.38 | Chg30d=+1.75% | Revisions=+25% | GrowthEPS=+4.5% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +50% (up=3, down=0)